Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccination against multiple myeloma

F K Stevenson1, C J Link, A Traynor

  • 1Tenovus Laboratory, Southampton University Hospitals Trust, UK.

Seminars in Hematology
|February 16, 1999
PubMed
Summary

DNA cancer vaccines aim to activate immune responses against tumor antigens, overcoming immune tolerance. Strategies include novel vectors and gene gun delivery for therapeutic vaccination against cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective cohort study of the anesthetic management of postpartum tubal ligation.

International journal of obstetric anesthesia·2024
Same author

An analysis of emerging food safety and fraud risks of novel insect proteins within complex supply chains.

NPJ science of food·2024
Same author

A survey of United States obstetric anesthesiologists' perceived value of obstetric anesthesiology fellowship.

International journal of obstetric anesthesia·2023
Same author

Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.

Journal of internal medicine·2017
Same author

IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.

Leukemia·2016
Same author

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.

Leukemia·2014

Area of Science:

  • Oncology
  • Immunology
  • Gene Therapy

Background:

  • Antitumor therapy research explores DNA and noncoding nucleotides for gene vaccination.
  • Cancer vaccines are therapeutic, aiming to eliminate residual disease after traditional treatments.
  • Tumor antigens often fail to elicit immune responses due to a lack of danger signals, leading to immune tolerance.

Purpose of the Study:

  • To review various gene vaccination strategies for antitumor therapy.
  • To explore methods for activating immune responses against tumor antigens.
  • To overcome immune tolerance in cancer patients.

Main Methods:

  • Review of strategies including scFv-tetanus toxin fusion constructs.
  • Utilizing novel herpes simplex virus 1 (HSV-1) vectors for in vivo gene delivery.

Related Experiment Videos

  • Gene gun-mediated delivery of granulocyte-macrophage colony-stimulating factor (GM-CSF) cDNA tumor cell vaccines.

    • Main Results:

    • DNA vaccination shows promise for cancer, analogous to its success against viral diseases.
    • Therapeutic cancer vaccines may be optimally timed during remission to eradicate residual disease.
    • Overcoming immune tolerance is crucial for effective DNA cancer vaccines.

    Conclusions:

    • Multiple gene vaccination approaches are under investigation for cancer treatment.
    • Effective cancer vaccines must elicit immune responses despite pre-existing tumor tolerance.
    • The inclusion of danger signals may be critical for activating T-cell responses against tumor antigens.